Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-09

FDA Approved: ZOLMITRIPTAN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Zolmitriptan filed by Zydus Pharmaceuticals USA Inc., indicating regulatory approval for a modification to the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

SUPPL AP for ZOLMITRIPTAN (ZOLMITRIPTAN)